Table 2 Descriptive statistics of baseline substance use and mental health among trans women living with HIV, mSN study, 2022, N = 42

Substance use

 Recent substances used^{a, b}

  Alcohol

36 (85.7)

  Methamphetamine

20 (47.6)

  Cocaine

10 (23.8)

  Opioids^c

3 (7.1)

  Polysubstance^d

10 (23.8)

 Frequency of use^a,e

  Alcohol (N = 36)

   Did not use in the past year

13 (36.1)

   Monthly

9 (25.0)

   2–4 times a month

7 (19.4)

   2–3 times a week

3 (8.3)

   4 or more times a week

4 (11.1)

  Methamphetamine (N = 20)

   Monthly

7 (35.0)

   Weekly

4 (20.0)

   Daily

9 (45.0)

  Crack/cocaine (N = 10)

   Monthly

3 (30.0)

   Weekly

2 (20.0)

   Daily

5 (50.0)

  Opioids^b (N = 3)

   Monthly

0 (0.0)

   Weekly

1 (33.3)

   Daily

2 (66.7)

  Polysubstance^d use (N = 10)

   Monthly

3 (30.0)

   Weekly

1 (10.0)

   Daily

6 (60.0)

 Positive screening for Alcohol Use Disorder (AUDIT-C ≥ 3)

14 (33.3)

 Positive screening for a Drug Use Disorder (DAST-10 ≥ 6)

12 (28.6)

Mental health

 Anxiety or depression symptom level

  Not clinically significant for anxiety or depression symptom level (PHQ-4, 0–2)

7 (16.7)

  Mild symptoms level (PHQ-4, 3–5)

15 (35.7)

  Moderate symptoms level (PHQ-4, 6–8)

12 (28.6)

  Severe symptoms level (PHQ-4, 9–12)

8 (19.1)

 Positive screening for anxiety disorder (PHQ-4, anxiety subscale≥3)

22 (52.4)

 Positive screening for depression disorder (PHQ-4, depression subscale ≥3)

17 (40.5)

 Psychological distress

 No psychological distress (Kessler score, 0)

1 (2.4)

 Low psychological distress (Kessler score, 1–5)

5 (11.9)

 Moderate psychological distress (Kessler score, 6–10)

16 (38.1)

 High psychological distress (Kessler score, 11–24)

20 (47.6)

 Indication of serious psychological distress (Kessler score ≥ 13)

14 (33.3)